NAYA Biosciences Inc. (NAYA)
0.38
0.01 (2.70%)
At close: Mar 03, 2025, 12:03 PM
No 1D chart data available
| Bid | 0.37 |
| Market Cap | 2.66M |
| Revenue (ttm) | 11.36M |
| Net Income (ttm) | -13.62M |
| EPS (ttm) | -1.01 |
| PE Ratio (ttm) | -0.37 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 0.39 |
| Volume | 60,039 |
| Avg. Volume (20D) | 175,072 |
| Open | 0.37 |
| Previous Close | 0.37 |
| Day's Range | 0.37 - 0.39 |
| 52-Week Range | 0.34 - 3.50 |
| Beta | 1.62 |
About NAYA
INVO Bioscience is a medical device company providing devices and products for infertility diagnosis. Its flagship product is INVOcell, a reproductive technology that allows fertilization and early embryo development to take place within the woman’s body....
Industry Medical/Nursing Services
Sector Healthcare
IPO Date Nov 2, 2020
Employees 30
Stock Exchange NASDAQ
Ticker Symbol NAYA
Website http://www.nayabiosciences.com
Analyst Forecast
According to 1 analyst ratings, the average rating for NAYA stock is "Buy." The 12-month stock price forecast is $2, which is an increase of 433.33% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
1 month ago
-38.53%
NAYA Biosciences shares are trading lower after th...
Unlock content with
Pro Subscription
1 month ago
+9.74%
NAYA Biosciences shares are trading higher after the company announced the development of NY-500 novel AI-optimized PD X VEGF bifunctional antibody.